ArticleCancers2020

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study.

Beate Schultheis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.